诺和诺德（NYSE: NVO）通过OpenAI的Rosalind平台扩大AI药物研发布局
Novo Nordisk (NYSE: NVO) Expands AI Drug Discovery Push Through OpenAI's Rosalind Platform
来源 www.foreignpolicyjournal.com
报道
- 诺和诺德（NYSE: NVO）通过OpenAI的Rosalind平台扩大AI药物研发布局 Novo Nordisk (NYSE: NVO) Expands AI Drug Discovery Push Through OpenAI's Rosalind Platform www.foreignpolicyjournal.com · · 首发